Peripherally inserted central catheter-associated mast cell activation syndrome: clinical evidence
CADTH
Record ID 32014000121
English
Authors' recommendations:
No literature was identified regarding the risk of mast cell activation syndrome in patients receiving peripherally inserted central catheters or the risk factors associated with the development of mast cell activation syndrome.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/jul-2013/RB0603%20PICC%20safety%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Mastocytosis
- Syndrome
- Catheters
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.